CFTR and cystic fibrosis: Additionally, in cystic fibrosis research, patient-derived intestinal and airway organoids were successfully employed to evaluate the modulator efficacy of the CF transmembrane conductance regulator (CFTR) and optimize personalized treatment strategies[447].